Towards disease modifying therapies of neurodegenerative diseases

Research report (imported) 2016 - Max Planck Institute for Biophysical Chemistry

Authors
Ryazanov, Sergey;  Leonov, Andrei; Griesinger, Christian
Departments
NMR-basierte Strukturbiologie
DOI
Summary
Neurodegenerative diseases‘ hallmark is the aggregation of mostly intrinsically disordered proteins. Getting fundamental insights into the structural biology of these proteins, it was possible to identify oligomers as an attractive target for disease modifying therapies. The compound anle138b is bearing the required properties regarding modification of aggregation pathways, and is also orally bioavailable.

For the full text, see the German version.

Go to Editor View